10052835A novel method for remote assessment of exercise capacity using a telehealth platform and a wearable medical deviceClosedCollaborative R&DInnovate UK**BACKGROUND:** Pulmonary Rehabilitation (PR) is a medical intervention, normally held in group classes in community facilities, improving lung function in patients with chronic lung diseases. Spirit Digital have developed a home-based PR intervention (CTV-PR) that delivers video-led exercises and written education, and mechanisms to encourage lasting engagement with the exercise programme. **CHALLENGE:** International guidelines state that PR exercises should be individually prescribed based on baseline exercise capacity measurements taken in clinic. Neither CTV-PR nor competitor solutions can measure exercise capacity remotely. **There is an unmet need for exercise capacity assessment at home.** **VISION:** Collaborative R&D with the University of Strathclyde (UoS) and UK SME Waire Health to develop a new functionality for CTV-PR that facilitates exercise capacity assessment in the home. **INNOVATION:** CTV-PR will enable formal exercise capacity assessment that is self-administered by the patient in their own home using wearable technology and innovative software features. Spirit Digital has completed in-depth searches to identify if anything like their idea has been proposed by others. This includes searches of: * Patent databases. * Databases published by the Governments of the UK, USA, Canada, Australia, and New Zealand of funded academic and industrial R&D. * Wider internet searches via Google. The consortium could not find any similar approaches to automating exercise capacity assessments in a patient's own home. As such, they have concluded that this is the first time the proposed approach has been attempted. **TIMELINESS:** * Alignment with NHS Reset and Recovery initiatives (CTV-PR provides new Covid-19 secure ways of working). * CTV-PR supports expansion of PR services enshrined within the NHS Long Term Plan (referral increase target: 13% to 60% by 2023).